Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Sexually Transmitted Diseases

  Free Subscription


Articles published in Gynecol Oncol

Retrieve available abstracts of 36 articles:
HTML format
Text format



Single Articles


    January 2012
  1. GYLLENSTEN U , Gustavsson I, Lindell M, Wilander E, et al
    Primary high-risk HPV screening for cervical cancer in post-menopausal women.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



  2. MONSONEGO J , Hudgens MG, Zerat L, Zerat JC, et al
    Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study).
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  3. NICOL AF , Monsonego J
    Summary of the Eurogin 2011 conference: Highlighting the recent advances in HPV-related cancers.
    Gynecol Oncol. 2011;123:179-81.
    PubMed     Text format     Related articles   



    August 2011
  4. SHEN-GUNTHER J , Shank JJ, Ta V
    Gardasil HPV vaccination: Surveillance of vaccine usage and adherence in a military population.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  5. TROPE A , Jonassen CM, Sjoborg KD, Nygard M, et al
    Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  6. SHEN-GUNTHER J , Yu X
    HPV molecular assays: Defining analytical and clinical performance characteristics for cervical cytology specimens.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  7. OVESTAD IT , Vennestrom U, Andersen L, Gudlaugsson E, et al
    Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  8. VALARI O , Koliopoulos G, Karakitsos P, Valasoulis G, et al
    Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: Predictors and clinical implications.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  9. DEL PINO M , Rodriguez-Carunchio L, Alonso I, Torne A, et al
    Clinical, colposcopic and pathological characteristics of cervical and vaginal high-grade lesions negative for HPV by Hybrid Capture 2.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  10. MENNINI FS , Capone A, Favato G
    The use of an "old-fashioned method" to assess the clinical and economic impact of a HPV vaccination program.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   



    March 2011
  11. CORRENTI M , Medina F, Cavazza ME, Rennola A, et al
    Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  12. PETRY KU , Schmidt D, Scherbring S, Luyten A, et al
    Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  13. BELL MC , Schmidt-Grimminger D, Jacobsen C, Chauhan SC, et al
    Risk factors for HPV infection among American Indian and white women in the Northern Plains.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  14. SIDERI M , Igidbashian S, Boveri S, Radice D, et al
    Age distribution of HPV genotypes in cervical intraepithelial neoplasia.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  15. CAPRI S , Gasparini R, Panatto D, Demarteau N, et al
    Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: The potential impact of different cross-protection profiles.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  16. KANG WD , Kim CH, Cho MK, Kim JW, et al
    HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  17. KINNEY W , Fetterman B, Cox JT, Lorey T, et al
    Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



  18. TORNESELLO ML , Losito S, Benincasa G, Fulciniti F, et al
    Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  19. BURGER EA , Kornor H, Klemp M, Lauvrak V, et al
    HPV mRNA tests for the detection of cervical intraepithelial neoplasia: A systematic review.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  20. LI Y , Zeng WJ, Ye F, Wang XY, et al
    Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  21. COQUILLARD G , Palao B, Patterson BK
    Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  22. ZENG WJ , Li Y, Fei HL, Cheng XD, et al
    The value of p16ink4a expression by fluorescence in situ hybridization in triage for high risk HPV positive in cervical cancer screening.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  23. REUSCHENBACH M , Clad A, von Knebel Doeberitz C, Wentzensen N, et al
    Performance of p16(INK4a)-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  24. STANLEY M
    Potential mechanisms for HPV vaccine-induced long-term protection.
    Gynecol Oncol. 2010;118.
    PubMed     Text format     Related articles    Abstract available



  25. SCHILLER JT , Day PM, Kines RC
    Current understanding of the mechanism of HPV infection.
    Gynecol Oncol. 2010;118.
    PubMed     Text format     Related articles    Abstract available



    May 2010
  26. EINSTEIN MH , Martens MG, Garcia FA, Ferris DG, et al
    Clinical validation of the Cervista(R) HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  27. STANLEY M
    Pathology and epidemiology of HPV infection in females.
    Gynecol Oncol. 2010;117.
    PubMed     Text format     Related articles    Abstract available



    April 2010
  28. HUH W , Einstein MH, Herzog TJ, Franco EL, et al
    What is the role of HPV typing in the United States now and in the next five years in a vaccinated population?
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  29. SJOEBORG KD , Trope A, Lie AK, Jonassen CM, et al
    HPV genotype distribution according to severity of cervical neoplasia.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



    March 2010
  30. DOWNS LS JR , Scarinci I, Einstein MH, Collins Y, et al
    Overcoming the barriers to HPV vaccination in high-risk populations in the US.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  31. QUINT KD , de Koning MN, van Doorn LJ, Quint WG, et al
    HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  32. CHAO FY , Chao A, Huang CC, Hsueh S, et al
    Defining detection threshold and improving analytical proficiency of HPV testing in clinical specimens.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



    February 2010
  33. LINDELL G , Nasman A, Jonsson C, Ehrsson RJ, et al
    Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  34. GIULIANO AR , Anic G, Nyitray AG
    Epidemiology and pathology of HPV disease in males.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  35. KANE MA
    Global implementation of human papillomavirus (HPV) vaccine: Lessons from hepatitis B vaccine.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



  36. ZIMET GD , Rosenthal SL
    HPV vaccine and males: Issues and challenges.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: